OrganiGram Holdings (TSE:OGI) has released an update.
Organigram Holdings has advanced its cannabis product selection with a $1M investment into Phylos Bioscience, aiming to meet consumer demand for new aromas and high-potency rare cannabinoids. With exclusive rights to high THCV cultivars, the company is enhancing its market position by diversifying its offerings, including unique auto-flower and rare cannabinoid products.
For further insights into TSE:OGI stock, check out TipRanks’ Stock Analysis page.
